Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Lysoclear
company
About
Lysoclear is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Life Science
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Lysoclear, Inc. is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease. The company is currently developing leads to treat atrophic “dry” age-related macular degeneration and Stargardt’s macular degeneration.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3M
Lysoclear has raised a total of
$3M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2018 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2018 | Series Unknown | $3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Lysoclear is funded by 1 investors.
Grapeseed.Bio
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Grapeseed.Bio
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
